The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Trump Allows Commercial Fishing in Protected New England Waters
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages 



